Well I have never been more transfixed by a pending 4C tham I am waiting for the next qtrly for MLA. It signals the confirmation of the turning point for what has been a long and rather depressing story that has been the tale of BMDI, Tuta and culminating with Medical Australia.
While the Market had given up on MLA its Management certainly has not. Putting together a global supply chain that seems to be "Worlds Best Practice". Coupled with managements ability to partner peers of Global scale and their eye for a bolt on acquisition seems to have landed us in a position of an unheralded pivot point in our companies history.
I say pivot point because we are well beyond turn around time with little recognition from the broader Market and if the pending cash flow report confirms what Management have hinted at, i beleive the Market may well have been caught snoozing.
The 4c will only be a hint because until we see the guts of the figures in the half yearly we may be well counselled to be cautious. MD however has been very clear that the supply chain is in place and is fully expensed at supply levels as at the last qrtrly so any additional volume going through the supply chain should not add to supply costs in any significant manner outside of applyng the 60 % gross profit model. This why I think the 4C is the Key.
So, expect the 4C at the worst within 10 days and more like 7 or even 5.
Let the count down begin
Viney
MLA Price at posting:
34.0¢ Sentiment: Buy Disclosure: Held
